Next Article in Journal
Success Rates of Monitoring for Healthcare Professionals with a Substance Use Disorder: A Meta-Analysis
Next Article in Special Issue
Gastrointestinal Dysfunction in Parkinson’s Disease
Previous Article in Journal
Prognostic Impact of Percutaneous Coronary Intervention of Chronic Total Occlusion in Acute and Periprocedural Myocardial Infarction
Previous Article in Special Issue
Effects of Transanal Irrigation on Gut Microbiota in Pediatric Patients with Spina Bifida
Open AccessArticle

The Monitoring Efficacy of Neurogenic Bowel Dysfunction Treatment on Response (MENTOR) in a Non-Hospital Setting

1
Department of Hepatology and Gastroenterology, Aarhus University Hospital of Aarhus, DK8200 Aarhus N, Denmark
2
GI Physiology Unit, University College Hospital, London NW1 2BU, UK
3
Department of Surgery, Aarhus University Hospital of Aarhus, DK8200 Aarhus N, Denmark
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2021, 10(2), 263; https://doi.org/10.3390/jcm10020263
Received: 22 December 2020 / Revised: 5 January 2021 / Accepted: 7 January 2021 / Published: 12 January 2021
(This article belongs to the Special Issue Neurogenic Bowel Dysfunction)
Background: Most patients with a spinal cord injury (SCI) suffer from neurogenic bowel dysfunction (NBD). In spite of well-established treatment algorithms, NBD is often insufficiently managed. The Monitoring Efficacy of Neurogenic bowel dysfunction Treatment On Response (MENTOR) has been validated in a hospital setting as a tool to support clinical decision making in individual patients. The objective of the present study was to describe clinical decisions recommended by the MENTOR (either “monitor”, “discuss” or “act”) and the use of the tool to monitor NBD in a non-hospital setting. Methods: A questionnaire describing background data, the MENTOR, ability to work and participation in various social activities was sent by mail to all members of The Danish Paraplegic Association. Results: Among 1316 members, 716 (54%) responded, 429 men (61%) and 278 women (39%), aged 18 to 92 (median 61) years. Based on MENTOR, the recommended clinical decision is to monitor treatment of NBD in 281 (44%), discuss change in treatment in 175 (27%) and act/change treatment in 181 (28%). A recommendation to discuss or change treatment was associated with increasing age of the respondent (p = 0.016) and with impaired ability to work or participate in social activities (p < 0.0001). Conclusion: A surprisingly high proportion of persons with SCI have an unmet need for improved bowel care. The MENTOR holds promise as a tool for evaluation of treatment of NBD in a non-hospital setting. View Full-Text
Keywords: SCI; MENTOR; NBD; constipation; fecal incontinence SCI; MENTOR; NBD; constipation; fecal incontinence
Show Figures

Figure 1

MDPI and ACS Style

Studsgaard Slot, S.D.; Baunwall, S.M.D.; Emmanuel, A.; Christensen, P.; Krogh, K. The Monitoring Efficacy of Neurogenic Bowel Dysfunction Treatment on Response (MENTOR) in a Non-Hospital Setting. J. Clin. Med. 2021, 10, 263. https://doi.org/10.3390/jcm10020263

AMA Style

Studsgaard Slot SD, Baunwall SMD, Emmanuel A, Christensen P, Krogh K. The Monitoring Efficacy of Neurogenic Bowel Dysfunction Treatment on Response (MENTOR) in a Non-Hospital Setting. Journal of Clinical Medicine. 2021; 10(2):263. https://doi.org/10.3390/jcm10020263

Chicago/Turabian Style

Studsgaard Slot, Sofie D.; Baunwall, Simon M.D.; Emmanuel, Anton; Christensen, Peter; Krogh, Klaus. 2021. "The Monitoring Efficacy of Neurogenic Bowel Dysfunction Treatment on Response (MENTOR) in a Non-Hospital Setting" J. Clin. Med. 10, no. 2: 263. https://doi.org/10.3390/jcm10020263

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop